UNI-DUR Drug Patent Profile
✉ Email this page to a colleague
When do Uni-dur patents expire, and what generic alternatives are available?
Uni-dur is a drug marketed by Schering and is included in two NDAs.
The generic ingredient in UNI-DUR is theophylline. There are thirty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the theophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Uni-dur
A generic version of UNI-DUR was approved as theophylline by RHODES PHARMS on September 1st, 1982.
Summary for UNI-DUR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 171 |
Patent Applications: | 3,874 |
Formulation / Manufacturing: | see details |
DailyMed Link: | UNI-DUR at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for UNI-DUR
US Patents and Regulatory Information for UNI-DUR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | UNI-DUR | theophylline | TABLET, EXTENDED RELEASE;ORAL | 089822-001 | Jan 4, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | UNI-DUR | theophylline | TABLET, EXTENDED RELEASE;ORAL | 089823-001 | Jan 4, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |